SLDB 250117 2.50C (SLDB250117C2500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

SLDB250117C2500

Watchlist

0.00
0.000.00%

15min DelayClose Jan 8 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Barclays Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $15
Moomoo NewsJan 9 04:34 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Biomea Fusion (BMEA) and Solid Biosciences (SLDB)
TipRanksJan 9 04:10 ET · Ratings
Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswireJan 8 16:05 ET
Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment
PR NewswireJan 8 14:48 ET
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
BenzingaJan 8 14:09 ET
Solid Bio Draws Buy From Truist on Valuation and Catalysts
Seeking AlphaJan 8 11:54 ET

Comments

Blick

Jan 8 03:31

$Solid Biosciences (SLDB.US)$ 🤔

Jaguar8

Jan 7 20:00

⚫️ Watchlist JANUARY 8,2025, Wednesday NFA

NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...

Jaguar8

Jan 7 15:15

NEWS

$Solid Biosciences (SLDB.US)$
Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreich's Ataxia
Tuesday, 7th January at 4:15 pm
- SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting the CNS and cardiac manifestations of Friedreich's ataxia -
- Dual route of administration enables direct delivery of AAV-based gene therapy to the cerebellum and...

Trytosaveabit

Dec 19, 2024 14:57

Had to delete previous post! Grrrr!

$Solid Biosciences (SLDB.US)$ Apologies! It seems PRNewswire tagged wrong ticker! Grrrr! Now i gotta figure ticker they should tagged! Hehehe

This_Guy

Nov 24, 2024 18:54

$Solid Biosciences (SLDB.US)$
RA capital and perspective advisors are both investors here. They also are invested in $Bright Minds Biosciences (DRUG.US)$
DRUG ran recently as we all know but also ran 3000% in 2022. Each time RA Capital and perspective advisors were invested and both times there were private placements after they ran.
In 2021 SLDB ran 450%, RA Capital and perspective advisors both invested and a private placement after it ran.
SLDB has not had a major run since but maybe it will a...